APA (7th ed.) Citation

Saltos, A. N., Arrowood, C., Beasley, G. M., Ronald, J., El-Haddad, G., Gray, J. E., . . . Ready, N. E. (2023). 629-D The anti-tumor activity of IFNβ and membrane-stable CD40L expressing oncolytic virus MEM-288 in NSCLC patients is associated with modulation of the tumor microenvironment and systemic immune response. Journal for immunotherapy of cancer, 11(Suppl 2), A1809. https://doi.org/10.1136/jitc-2023-SITC2023.0629-D

Chicago Style (17th ed.) Citation

Saltos, Andreas N., et al. "629-D The Anti-tumor Activity of IFNβ and Membrane-stable CD40L Expressing Oncolytic Virus MEM-288 in NSCLC Patients Is Associated with Modulation of the Tumor Microenvironment and Systemic Immune Response." Journal for Immunotherapy of Cancer 11, no. Suppl 2 (2023): A1809. https://doi.org/10.1136/jitc-2023-SITC2023.0629-D.

MLA (9th ed.) Citation

Saltos, Andreas N., et al. "629-D The Anti-tumor Activity of IFNβ and Membrane-stable CD40L Expressing Oncolytic Virus MEM-288 in NSCLC Patients Is Associated with Modulation of the Tumor Microenvironment and Systemic Immune Response." Journal for Immunotherapy of Cancer, vol. 11, no. Suppl 2, 2023, p. A1809, https://doi.org/10.1136/jitc-2023-SITC2023.0629-D.